Exact Mass: 487.30625860000004

Exact Mass Matches: 487.30625860000004

Found 500 metabolites which its exact mass value is equals to given mass value 487.30625860000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(4Z,7Z,10Z,13Z,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine

3-[(17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,11Z,13Z,16Z,19Z)-10-Hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine

3-[(10-hydroxydocosa-4,7,11,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7E,9E,13Z,16Z,19Z)-11-Hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine

3-[(11-hydroxydocosa-4,7,9,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,14E,16Z,19Z)-13-Hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine

3-[(13-hydroxydocosa-4,7,10,14,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z,17Z,19Z)-16-Hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine

3-[(16-hydroxydocosa-4,7,10,13,17,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z,16E,18E)-20-Hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine

3-[(20-hydroxydocosa-4,7,10,13,16,18-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine

3-[(4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine

3-[(7-hydroxydocosa-4,8,10,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4E,6E,10Z,13Z,16Z,19Z)-8-Hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine

3-[(8-hydroxydocosa-4,6,10,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z,16Z)-18-(3-Ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine

3-{[18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoyl]oxy}-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-Pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine

3-({15-[3-(pent-2-en-1-yl)oxiran-2-yl]pentadeca-4,7,10,13-tetraenoyl}oxy)-4-(trimethylazaniumyl)butanoic acid

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Talaroconvolutin A

Talaroconvolutin A

C32H41NO3 (487.3086276)


An octahydronaphthalene with formula C32H41NO3. It is a fungal metabolite isolated from Talaromyces convolutus and is an inducer of ferroptosis in colorectal cancer cells.

   

Sulpinine B

Sulpinine B

C32H41NO3 (487.3086276)


   

NPTX 11

NPTX 11

C24H37N7O4 (487.29068820000003)


   

Beauveriolide III

Beauveriolide III

C27H41N3O5 (487.30460560000006)


   

SCHEMBL16431315

SCHEMBL16431315

C25H45NO8 (487.314501)


   

Beauverolide H

Beauverolide H

C27H41N3O5 (487.30460560000006)


   

Kimbasine A

Kimbasine A

C29H45NO5 (487.32975600000003)


   

Batzelladine L|beauveriolide I|beauverolide I

Batzelladine L|beauveriolide I|beauverolide I

C27H41N3O5 (487.30460560000006)


   

Ambruticin VS 4

Ambruticin VS 4

C29H45NO5 (487.32975600000003)


   

C29H45NO5

C29H45NO5 (487.32975600000003)


   

C31H41N3O2

C31H41N3O2 (487.3198606)


   

Oteromycin

Oteromycin

C32H41NO3 (487.3086276)


   

3-(3-methylcrotonyl)cassain

3-(3-methylcrotonyl)cassain

C29H45NO5 (487.32975600000003)


   

Cordycepeptide A

Cordycepeptide A

C27H41N3O5 (487.30460560000006)


   

23-O-Acetyl-12beta-hydroxy-solasodin

23-O-Acetyl-12beta-hydroxy-solasodin

C29H45NO5 (487.32975600000003)


   

Piericidin D4

Piericidin D4

C29H45NO5 (487.32975600000003)


   

Asn Val Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]hexanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Trp Leu Arg

Trp Leu Arg

C24H37N7O4 (487.29068820000003)


   

Asn Lys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-3-methylbutanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Trp Arg Leu

Trp Arg Leu

C24H37N7O4 (487.29068820000003)


   

Leu Arg Trp

Leu Arg Trp

C24H37N7O4 (487.29068820000003)


   

Thr Ile Val Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Trp

Arg Leu Trp

C24H37N7O4 (487.29068820000003)


   

Beauverolide I

Beauverolide I

C27H41N3O5 (487.30460560000006)


   

Ala Ile Val Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Ile Trp Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Lys Asn Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Ala Lys Arg Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

C19H37N9O6 (487.2866662)


   

Ala Leu Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Leu Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Asn Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Ala Asn Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Ala Arg Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]hexanamido]-3-carbamoylpropanoic acid

C19H37N9O6 (487.2866662)


   

Ala Arg Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Ala Val Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Val Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Val Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Val Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Trp Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Trp Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Trp Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ala Trp Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Asp Ile Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Ile Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Ile Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Ile Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-4-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Leu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-4-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Ile Lys Val

(4S)-4-amino-4-{[(1S,2S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Ile Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylpentanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Ile Val

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-methylbutyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Leu Val

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-3-methylbutyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Val Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Leu Lys Val

(4S)-4-amino-4-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Leu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-methylpentanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Phe Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C25H37N5O5 (487.27945520000003)


   

Phe Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C25H37N5O5 (487.27945520000003)


   

Phe Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Ile Ile Trp

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Ile Leu Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Ile Trp Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Ile Trp Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Lys Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]-5-carbamimidamidopentanoic acid

C20H41N9O5 (487.32304960000005)


   

Gly Lys Gln Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Gly Lys Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-5-carbamimidamidopentanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Gly Lys Arg Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C19H37N9O6 (487.2866662)


   

Gly Leu Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Leu Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Leu Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Leu Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Gln Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]hexanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Gly Gln Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Gly Arg Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]hexanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Gly Arg Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]hexanamido]-4-carbamoylbutanoic acid

C19H37N9O6 (487.2866662)


   

Gly Arg Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Gly Trp Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Trp Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Trp Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Gly Trp Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Ala Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Ala Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Asp Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Asp Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Asp Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Asp Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Glu Lys Val

(4S)-4-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-4-[(2S,3S)-2-amino-3-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Glu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carboxybutanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Gly Ile Trp

(2S)-2-[(2S,3S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Gly Leu Trp

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Gly Trp Ile

(2S,3S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Gly Trp Leu

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Ile Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Ile Gly Trp

(2S)-2-{2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Ile Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Ile Arg Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ile Ser Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ile Trp Gly

2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Ile Lys Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Asp Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Glu Val

(4S)-4-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Leu Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Met Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Ile Lys Pro Met

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Ile Lys Val Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Leu Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Leu Gly Trp

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Leu Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Leu Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Leu Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Leu Trp Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Ile Met Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Ile Met Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Ile Pro Lys Met

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Ile Pro Met Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Ile Arg Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Thr Arg Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Thr Val Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Val Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Val Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Val Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Val Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Val Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Val Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Trp Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Trp Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Trp Gly Leu

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Ile Trp Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Ile Trp Leu Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Ile Trp Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]propanoic acid

C25H37N5O5 (487.27945520000003)


   

Lys Ala Asn Arg

(2S)-5-carbamimidamido-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]pentanoic acid

C19H37N9O6 (487.2866662)


   

Lys Ala Arg Asn

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]pentanamido]-3-carbamoylpropanoic acid

C19H37N9O6 (487.2866662)


   

Lys Asp Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asp Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asp Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asp Leu Leu

(2S)-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Ile Val

(4S)-4-{[(1S,2S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-methylbutyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Leu Val

(4S)-4-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-3-methylbutyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Val Leu

(2S)-2-[(2S)-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Phe Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C25H37N5O5 (487.27945520000003)


   

Lys Gly Lys Arg

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]-5-carbamimidamidopentanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Gly Gln Arg

(2S)-5-carbamimidamido-2-[(2S)-4-carbamoyl-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}butanamido]pentanoic acid

C19H37N9O6 (487.2866662)


   

Lys Gly Arg Lys

(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}pentanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Gly Arg Gln

(2S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}pentanamido]-4-carbamoylbutanoic acid

C19H37N9O6 (487.2866662)


   

Lys Ile Asp Ile

(2S,3S)-2-[(2S)-3-carboxy-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Asp Leu

(2S)-2-[(2S)-3-carboxy-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Glu Val

(4S)-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-4-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Ile Asp

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Leu Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Met Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Lys Ile Pro Met

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Ile Val Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Lys Gly Arg

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}-5-carbamimidamidopentanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Lys Asn Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Lys Arg Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-5-carbamimidamidopentanamido]acetic acid

C20H41N9O5 (487.32304960000005)


   

Lys Lys Val Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Leu Asp Ile

(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Asp Leu

(2S)-2-[(2S)-3-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Glu Val

(4S)-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-4-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Lys Leu Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Leu Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Met Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Lys Met Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Lys Met Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Met Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Asn Ala Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]pentanoic acid

C19H37N9O6 (487.2866662)


   

Lys Asn Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]hexanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Asn Arg Ala

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]pentanamido]propanoic acid

C19H37N9O6 (487.2866662)


   

Lys Asn Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylbutanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Pro Phe Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C25H37N5O5 (487.27945520000003)


   

Lys Pro Ile Met

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Pro Leu Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Pro Met Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Pro Met Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Lys Pro Pro Phe

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C25H37N5O5 (487.27945520000003)


   

Lys Gln Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]acetamido}pentanoic acid

C19H37N9O6 (487.2866662)


   

Lys Gln Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]pentanamido]acetic acid

C19H37N9O6 (487.2866662)


   

Lys Arg Ala Asn

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]propanamido]-3-carbamoylpropanoic acid

C19H37N9O6 (487.2866662)


   

Lys Arg Gly Lys

(2S)-6-amino-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]acetamido}hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Arg Gly Gln

(2S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]acetamido}-4-carbamoylbutanoic acid

C19H37N9O6 (487.2866662)


   

Lys Arg Lys Gly

2-[(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]hexanamido]acetic acid

C20H41N9O5 (487.32304960000005)


   

Lys Arg Asn Ala

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-carbamoylpropanamido]propanoic acid

C19H37N9O6 (487.2866662)


   

Lys Arg Gln Gly

2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-4-carbamoylbutanamido]acetic acid

C19H37N9O6 (487.2866662)


   

Lys Val Glu Ile

(2S,3S)-2-[(2S)-4-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]butanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Glu Leu

(2S)-2-[(2S)-4-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]butanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]hexanamido]-3-carbamoylpropanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Val Leu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-4-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Asn Lys

(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]propanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ala Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Ala Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Asp Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Asp Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Asp Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Asp Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Glu Lys Val

(4S)-4-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-4-[(2S)-2-amino-4-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Glu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carboxybutanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Gly Ile Trp

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Gly Leu Trp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Gly Trp Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Gly Trp Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Ile Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Ile Gly Trp

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Ile Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Ile Arg Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ile Ser Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ile Trp Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Leu Lys Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Asp Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Glu Val

(4S)-4-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Leu Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Met Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Leu Lys Pro Met

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Leu Lys Val Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Leu Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Leu Gly Trp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Leu Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Leu Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Leu Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Leu Trp Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Leu Met Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Leu Met Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Leu Pro Lys Met

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Leu Pro Met Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Leu Arg Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Thr Arg Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Thr Val Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Val Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Val Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Val Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Val Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Val Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Val Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Trp Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-methylbutanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Trp Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Trp Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-4-methylpentanoic acid

C25H37N5O5 (487.27945520000003)


   

Leu Trp Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Leu Trp Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]acetic acid

C25H37N5O5 (487.27945520000003)


   

Met Ile Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Met Ile Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Lys Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Met Lys Leu Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Met Lys Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Lys Pro Leu

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Leu Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C22H41N5O5S (487.2828256000001)


   

Met Leu Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Pro Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Pro Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Pro Lys Leu

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}hexanamido]-4-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Met Pro Leu Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Asn Ala Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]hexanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Asn Ala Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-5-carbamimidamidopentanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Asn Lys Ala Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]propanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Asn Lys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]hexanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Asn Lys Arg Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-5-carbamimidamidopentanamido]propanoic acid

C19H37N9O6 (487.2866662)


   

Asn Arg Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]propanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Asn Arg Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]hexanamido]propanoic acid

C19H37N9O6 (487.2866662)


   

Pro Ile Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Ile Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Lys Ile Met

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Lys Leu Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Lys Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Lys Met Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Leu Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Leu Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Met Ile Lys

(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Met Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Met Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O5S (487.2828256000001)


   

Pro Met Leu Lys

(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]hexanoic acid

C22H41N5O5S (487.2828256000001)


   

Gln Gly Lys Arg

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}hexanamido]-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Gln Gly Arg Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-5-carbamimidamidopentanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Gln Lys Gly Arg

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]acetamido}-5-carbamimidamidopentanoic acid

C19H37N9O6 (487.2866662)


   

Gln Lys Arg Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-5-carbamimidamidopentanamido]acetic acid

C19H37N9O6 (487.2866662)


   

Gln Arg Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]acetamido}hexanoic acid

C19H37N9O6 (487.2866662)


   

Gln Arg Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]hexanamido]acetic acid

C19H37N9O6 (487.2866662)


   

Arg Ala Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]hexanamido]-3-carbamoylpropanoic acid

C19H37N9O6 (487.2866662)


   

Arg Ala Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-carbamoylpropanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Arg Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}hexanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Arg Gly Lys Gln

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}hexanamido]-4-carbamoylbutanoic acid

C19H37N9O6 (487.2866662)


   

Arg Gly Gln Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-4-carbamoylbutanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Arg Ile Ile Ser

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Leu Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Ser Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Ser Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Thr Val

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Val Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Lys Ala Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]propanamido]-3-carbamoylpropanoic acid

C19H37N9O6 (487.2866662)


   

Arg Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]acetamido}hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Arg Lys Gly Gln

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]acetamido}-4-carbamoylbutanoic acid

C19H37N9O6 (487.2866662)


   

Arg Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]hexanamido]acetic acid

C20H41N9O5 (487.32304960000005)


   

Arg Lys Asn Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-carbamoylpropanamido]propanoic acid

C19H37N9O6 (487.2866662)


   

Arg Lys Gln Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-4-carbamoylbutanamido]acetic acid

C19H37N9O6 (487.2866662)


   

Arg Leu Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Asn Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]propanamido]hexanoic acid

C19H37N9O6 (487.2866662)


   

Arg Asn Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]hexanamido]propanoic acid

C19H37N9O6 (487.2866662)


   

Arg Gln Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]acetamido}hexanoic acid

C19H37N9O6 (487.2866662)


   

Arg Gln Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]hexanamido]acetic acid

C19H37N9O6 (487.2866662)


   

Arg Ser Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Ile Val

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Leu Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Val Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Val Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Ile Arg

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Leu Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Arg Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Arg Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Ile Arg Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Leu Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Leu Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Glu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Glu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Glu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Glu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Ile Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Ile Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Ile Arg Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Ile Thr Arg

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Lys Glu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-carboxybutanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Glu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-carboxybutanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]hexanamido]-3-carbamoylpropanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Lys Leu Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-carbamoylpropanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Leu Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Leu Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Leu Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Leu Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Asn Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]hexanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Ile Arg

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Leu Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Arg Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Arg Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phosphoethanolamine

2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phosphoethanolamine

C25H46NO6P (487.30625860000004)


   

LPE O-20:4

2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phosphoethanolamine

C25H46NO6P (487.30625860000004)


   

1-Octanaminium,N-[2-[(2,2-dicyclopentylacetyl)oxy]ethyl]-N,N-diethyl-, bromide (1:1)

1-Octanaminium,N-[2-[(2,2-dicyclopentylacetyl)oxy]ethyl]-N,N-diethyl-, bromide (1:1)

C26H50BrNO2 (487.30247)


   

sodium glycocholate

sodium glycocholate

C26H42NNaO6 (487.29096720000007)


D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents Glycocholic acid sodium is an orally active bile acid with anticancer activity, targeting against pump resistance-related and non-pump resistance-related pathways[1]. Glycocholic acid sodium is an orally active bile acid with anticancer activity, targeting against pump resistance-related and non-pump resistance-related pathways[1].

   

Beauveriolide I

Beauveriolide I

C27H41N3O5 (487.30460560000006)


A cyclodepsipeptide with formula C27H41N3O5. It was originally isolated from the fungus Beauveria sp. FO-6979 during a screening program for inhibitors of lipid droplet accumulation in murine macrophages. It is an inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT) and effective at reducing atherogenic lesions of the artery and heart in mouse models.

   

Beauveriolide-I; SCH-58149

Beauveriolide-I; SCH-58149

C27H41N3O5 (487.30460560000006)


   

(4Z,7Z,10Z,13Z,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine

(4Z,7Z,10Z,13Z,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,11Z,13Z,16Z,19Z)-10-Hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine

(4Z,7Z,11Z,13Z,16Z,19Z)-10-Hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7E,9E,13Z,16Z,19Z)-11-Hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine

(4Z,7E,9E,13Z,16Z,19Z)-11-Hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,14E,16Z,19Z)-13-Hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine

(4Z,7Z,10Z,14E,16Z,19Z)-13-Hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z,17Z,19Z)-16-Hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine

(4Z,7Z,10Z,13Z,17Z,19Z)-16-Hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z,16E,18E)-20-Hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine

(4Z,7Z,10Z,13Z,16E,18E)-20-Hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine

(5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine

(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4E,6E,10Z,13Z,16Z,19Z)-8-Hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine

(4E,6E,10Z,13Z,16Z,19Z)-8-Hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z,16Z)-18-(3-Ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine

(4Z,7Z,10Z,13Z,16Z)-18-(3-Ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-Pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine

(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-Pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine

C29H45NO5 (487.32975600000003)


   

[3-methyl-4-(3-methylphenyl)-1-piperazinyl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)-4-piperidinyl]methanone

[3-methyl-4-(3-methylphenyl)-1-piperazinyl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)-4-piperidinyl]methanone

C28H37N7O (487.3059432)


   

(1S)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]-1-[4-(1-hydroxy-2-methylpropan-2-yl)phenyl]butan-1-ol

(1S)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]-1-[4-(1-hydroxy-2-methylpropan-2-yl)phenyl]butan-1-ol

C32H41NO3 (487.3086276)


   

N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

(2S,3S,3aR,9bR)-7-(cyclohexen-1-yl)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-7-(cyclohexen-1-yl)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C30H37N3O3 (487.2834772)


   

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-2-[oxo-[4-(phenylmethyl)-1-piperidinyl]methyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-2-[oxo-[4-(phenylmethyl)-1-piperidinyl]methyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

C30H37N3O3 (487.2834772)


   

N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C30H37N3O3 (487.2834772)


   

N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C30H37N3O3 (487.2834772)


   

(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C30H37N3O3 (487.2834772)


   

(2S,3S,3aR,9bR)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-2-[oxo-[4-(phenylmethyl)-1-piperidinyl]methyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

(2S,3S,3aR,9bR)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-2-[oxo-[4-(phenylmethyl)-1-piperidinyl]methyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

C30H37N3O3 (487.2834772)


   

HexCer 13:2;2O/6:0

HexCer 13:2;2O/6:0

C25H45NO8 (487.314501)


   

HexCer 15:2;2O/4:0

HexCer 15:2;2O/4:0

C25H45NO8 (487.314501)


   

HexCer 17:2;2O/2:0

HexCer 17:2;2O/2:0

C25H45NO8 (487.314501)


   

HexCer 16:2;2O/3:0

HexCer 16:2;2O/3:0

C25H45NO8 (487.314501)


   

HexCer 14:2;2O/5:0

HexCer 14:2;2O/5:0

C25H45NO8 (487.314501)


   

HexCer 12:2;2O/7:0

HexCer 12:2;2O/7:0

C25H45NO8 (487.314501)


   

2-aminoethyl [2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] hydrogen phosphate

2-aminoethyl [2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] hydrogen phosphate

C25H46NO6P (487.30625860000004)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodeca-4,8-diene-1-sulfonic acid

C25H45NO6S (487.29674300000005)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]trideca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]trideca-4,8-diene-1-sulfonic acid

C25H45NO6S (487.29674300000005)


   

NA-DOPA 20:2(11Z,14Z)

NA-DOPA 20:2(11Z,14Z)

C29H45NO5 (487.32975600000003)


   

CAR 22:6;OH

CAR 22:6;OH

C29H45NO5 (487.32975600000003)


   

ST 26:4;O4;Gly

ST 26:4;O4;Gly

C28H41NO6 (487.29337260000005)


   

ST 27:3;O3;Gly

ST 27:3;O3;Gly

C29H45NO5 (487.32975600000003)


   

ST 20:3;O;HexNAc

ST 20:3;O;HexNAc

C28H41NO6 (487.29337260000005)


   

ST 23:0;O3;Tau

ST 23:0;O3;Tau

C25H45NO6S (487.29674300000005)


   

(1s,2r,5s,7r,8r,11s,14s)-1,2-dimethyl-18-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

(1s,2r,5s,7r,8r,11s,14s)-1,2-dimethyl-18-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

C32H41NO3 (487.3086276)


   

[6-(2-{2-[5-(6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl)-3-methylhexa-1,4-dien-1-yl]-3-methylcyclopropyl}ethenyl)-5-hydroxy-4-(methylamino)oxan-2-yl]acetic acid

[6-(2-{2-[5-(6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl)-3-methylhexa-1,4-dien-1-yl]-3-methylcyclopropyl}ethenyl)-5-hydroxy-4-(methylamino)oxan-2-yl]acetic acid

C29H45NO5 (487.32975600000003)


   

(1s,4s,10s,12s)-12-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

(1s,4s,10s,12s)-12-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

C31H41N3O2 (487.3198606)


   

(2s)-n-(5-{[(2s)-2,5-diamino-1-hydroxypentylidene]amino}pentyl)-2-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}butanediimidic acid

(2s)-n-(5-{[(2s)-2,5-diamino-1-hydroxypentylidene]amino}pentyl)-2-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}butanediimidic acid

C24H37N7O4 (487.29068820000003)


   

23-o-acetyl-12β-hydroxysolasodine

23-O-acetyl-12β-hydroxysolasodine

C29H45NO5 (487.32975600000003)


{"Ingredient_id": "HBIN004134","Ingredient_name": "23-o-acetyl-12\u03b2-hydroxysolasodine","Alias": "23-O-acetyl-12\u03b2-hydroxysolasodine","Ingredient_formula": "C29H45NO5","Ingredient_Smile": "C29H45NO5","Ingredient_weight": "487.67","OB_score": "12.16578116","CAS_id": "117803-97-1","SymMap_id": "SMIT08805","TCMID_id": "37260","TCMSP_id": "MOL007352","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(3r,6s,9s,13s)-9-benzyl-3-[(2s)-butan-2-yl]-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-6-methyl-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

(3r,6s,9s,13s)-9-benzyl-3-[(2s)-butan-2-yl]-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-6-methyl-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)


   

(3r,6s,9s,13s)-9-benzyl-3-[(2r)-butan-2-yl]-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-6-methyl-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

(3r,6s,9s,13s)-9-benzyl-3-[(2r)-butan-2-yl]-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-6-methyl-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)


   

(5z)-3-[(1r,2s,4as,6s,8ar)-3,4a,6-trimethyl-2-[(2e,4r)-4-methylhex-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

(5z)-3-[(1r,2s,4as,6s,8ar)-3,4a,6-trimethyl-2-[(2e,4r)-4-methylhex-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

C32H41NO3 (487.3086276)


   

(5z)-3-[(1s,2s,4ar,6s,8ar)-3,4a,6-trimethyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

(5z)-3-[(1s,2s,4ar,6s,8ar)-3,4a,6-trimethyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

C32H41NO3 (487.3086276)


   

3-[3,4a,6-trimethyl-2-(4-methylhex-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

3-[3,4a,6-trimethyl-2-(4-methylhex-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

C32H41NO3 (487.3086276)


   

3-(acetyloxy)-4-(dodecanoyloxy)-n-(2-hydroxy-4-methoxy-4-oxobutyl)-2-methylpentanimidic acid

3-(acetyloxy)-4-(dodecanoyloxy)-n-(2-hydroxy-4-methoxy-4-oxobutyl)-2-methylpentanimidic acid

C25H45NO8 (487.314501)


   

[(2s,4s,5r,6s)-6-[(1e)-2-[(1s,2s,3r)-2-[(1e,3r,4e)-5-[(2r,6r)-6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl]-3-methylhexa-1,4-dien-1-yl]-3-methylcyclopropyl]ethenyl]-5-hydroxy-4-(methylamino)oxan-2-yl]acetic acid

[(2s,4s,5r,6s)-6-[(1e)-2-[(1s,2s,3r)-2-[(1e,3r,4e)-5-[(2r,6r)-6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl]-3-methylhexa-1,4-dien-1-yl]-3-methylcyclopropyl]ethenyl]-5-hydroxy-4-(methylamino)oxan-2-yl]acetic acid

C29H45NO5 (487.32975600000003)


   

(1s,2r,5s,7r,8r,11s,14s)-1,2-dimethyl-20-(2-methylbut-3-en-2-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

(1s,2r,5s,7r,8r,11s,14s)-1,2-dimethyl-20-(2-methylbut-3-en-2-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

C32H41NO3 (487.3086276)


   

1,2-dimethyl-18-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

1,2-dimethyl-18-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

C32H41NO3 (487.3086276)


   

1,2-dimethyl-20-(2-methylbut-3-en-2-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

1,2-dimethyl-20-(2-methylbut-3-en-2-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

C32H41NO3 (487.3086276)


   

(3r,6s,9s,13s)-9-benzyl-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

(3r,6s,9s,13s)-9-benzyl-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)


   

9-benzyl-13-(hexan-2-yl)-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

9-benzyl-13-(hexan-2-yl)-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)


   

(5z)-3-[(1r,2s,4as,6s,8ar)-3,4a,6-trimethyl-2-[(2e)-4-methylhex-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

(5z)-3-[(1r,2s,4as,6s,8ar)-3,4a,6-trimethyl-2-[(2e)-4-methylhex-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrol-2-ol

C32H41NO3 (487.3086276)


   

9-benzyl-13-hexyl-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

9-benzyl-13-hexyl-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)


   

(3r,6s,9s,13r)-9-benzyl-13-hexyl-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

(3r,6s,9s,13r)-9-benzyl-13-hexyl-5,8,11-trihydroxy-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)


   

3-(acetyloxy)-4-(dodecanoyloxy)-n-[(2r)-2-hydroxy-4-methoxy-4-oxobutyl]-2-methylpentanimidic acid

3-(acetyloxy)-4-(dodecanoyloxy)-n-[(2r)-2-hydroxy-4-methoxy-4-oxobutyl]-2-methylpentanimidic acid

C25H45NO8 (487.314501)


   

9-benzyl-13-(hexan-2-yl)-5,8,11-trihydroxy-6-methyl-3-(sec-butyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

9-benzyl-13-(hexan-2-yl)-5,8,11-trihydroxy-6-methyl-3-(sec-butyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H41N3O5 (487.30460560000006)